Skip to Main Content

Paper Details

Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma.
Cancers (Basel)
20
2021
PCNSL, Patients, Primary Central Nervous System Lymphoma, TMT, methotrexate, patient, patients, primary central nervous system lymphoma
Author NameAffiliation
Julia FurtnerMedical University of Vienna
Karl-Heinz NenningMedical University of Vienna
Thomas RoetzerMedical University of Vienna
Astrid E GramsMedical University of Innsbruck
Franz MarholdUniversity Hospital St. Poelten, Karl Landsteiner University of Health Sciences
Camillo Sherif
Johannes TrenklerInstitute of Neuroradiology, Kepler University Hospital, Johannes Kepler Universitat of Linz
Barbara KieselMedical University of Vienna
Georg WidhalmMedical University of Vienna
Anna S BerghoffMedical University of Vienna
Georg LangsMedical University of Vienna
Matthias PreusserMedical University of Vienna
Matthias PreusserMedical University of Vienna
  • 1 - 13

Datasets

Release 1.2